India should explore Sustainability-Linked Incentives (SLI) targeting innovations in the 12 principles of green chemistry
For 2026 onwards, CPHI and PMEC India are evolving into two distinct, specialized shows
Despite steep funding setbacks, the global HIV response has gained momentum in 2025 with the introduction of twice-yearly injectable LEN
ALBIS will present a selection of advanced materials from its broad healthcare portfolio
The event will be attended by 35,000+ industry professionals
These findings follow positive Phase 3 results presented earlier this year
Merck will showcase results in innovative solutions in HIV treatment and prevention
Brenntag Specialties will provide pharmaceutical manufacturers and biopharmaceutical companies with a reliable supply of high-purity, GMP-compliant acetates
This authorization follows FDA approval in June and WHO’s July recommendation adding twice-yearly lenacapavir as a PrEP option
The company’s acquisition of a 51 per cent stake in Saarathi Healthcare earlier this financial year boosted growth
Subscribe To Our Newsletter & Stay Updated
